v3.26.1
Shareholders' Equity (Details)
1 Months Ended 12 Months Ended
Jul. 09, 2024
USD ($)
Y
$ / shares
shares
Aug. 31, 2024
USD ($)
Apr. 30, 2023
shares
Dec. 31, 2025
USD ($)
$ / shares
shares
Dec. 31, 2024
USD ($)
$ / shares
shares
Jul. 08, 2024
$ / shares
Shareholders' Equity            
Shares issued price per share | $ / shares       $ 1.35 $ 6.4  
Exercise price of warrants | $ / shares       $ 1.35    
Issuance of common stock to vendors (in shares)       32,346 5,000  
Weighted average price (per share) | $ / shares       $ 2.37 $ 3.16  
Issuance of common stock upon exercise of warrant       225,000    
Percentage of numbers of shares issued upon exercise of existing warrants 150.00%          
Proceeds from the exercise of warrants | $       $ 305,241 $ 4,450,172  
Total issuance costs | $ $ 7,500,000       374,774  
Financial advisory, banker, and legal fees | $ 400,000          
Warrant modification - incremental value | $ $ 7,200,000       $ 7,177,683  
Pre-funded warrants            
Shareholders' Equity            
Exercise price of warrants | $ / shares       $ 0.001 $ 0.02  
Issuance of common stock upon exercise of warrant       1,491,480 537,500  
New warrants            
Shareholders' Equity            
Exercise price of warrants | $ / shares         $ 6.4  
Issuance of common stock upon exercise of warrant         34,816  
Aggregate warrants issued (shares) 1,054,688          
New warrants | Dividend yield            
Shareholders' Equity            
Warrants and Rights Outstanding 0          
New warrants | Expected term            
Shareholders' Equity            
Warrants and Rights Outstanding | Y 5          
New warrants | volatility            
Shareholders' Equity            
Warrants and Rights Outstanding 1.2725          
New warrants | Risk free interest            
Shareholders' Equity            
Warrants and Rights Outstanding 0.0424          
Existing Warrants            
Shareholders' Equity            
Exercise price of warrants | $ / shares $ 6         $ 6.4
Issuance of common stock upon exercise of warrant 703,125          
Proceeds from the exercise of warrants | $ $ 4,200,000          
Warrant modification and new warrants            
Shareholders' Equity            
New warrants issued | $ $ 7,200,000          
Public offering            
Shareholders' Equity            
Number of shares issued       4,064,080    
Public offering | Pre-funded warrants            
Shareholders' Equity            
Number of common warrants to purchase shares issued       1,491,480 537,500  
At Market Issuance sales            
Shareholders' Equity            
Number of shares issued       1,758,725 229,078  
Weighted average price (per share) | $ / shares       $ 2.68 $ 4.72  
Percentage of gross proceeds from sales of shares under ATM   3.00%        
Aggregate offering price | $   $ 5,800,000        
Convertible debt | Pontifax            
Shareholders' Equity            
Issuance of common stock from conversion of debt (in shares)     36,790   36,790  
Conversion price | $ / shares         $ 6.91  
Common Stock            
Shareholders' Equity            
Number of shares issued       1,758,725 229,078  
Issuance of common stock to vendors (in shares)       32,346 5,000  
Issuance of common stock from conversion of debt (in shares)         36,790  
Common Stock | New warrants            
Shareholders' Equity            
Issuance of common stock upon exercise of warrant       225,000 34,816  
Common Stock | Existing Warrants            
Shareholders' Equity            
Issuance of common stock upon exercise of warrant         703,125  
Common Stock | Public offering            
Shareholders' Equity            
Number of shares issued         204,694  
Common Stock | Convertible debt            
Shareholders' Equity            
Reduction in conversion price as percentage of closing price of the common stock on the day before the delivery of the conversion notice         90.00%